Tam Anh General Hospital Honored as Southeast Asia Leading Provider of Reproductive Support at Vietnam-ASEAN Economic Cooperation Forum 2026

Tam Anh General Hospital has been officially recognized as the premier institution for reproductive support in Southeast Asia, receiving the prestigious No. 1 in Southeast Asia for Reproductive Support certification from the Asia Business Development Research Center. The accolade was presented during the Vietnam-ASEAN Economic Cooperation Forum 2026, held on April 18 in Singapore. This landmark achievement highlights the hospital’s ascending influence within the regional healthcare landscape, marking a significant milestone for Vietnam’s medical sector as it seeks to establish itself as a hub for high-tech medical services.

In addition to the top honor for reproductive support, the Tam Anh General Hospital system secured two other major ASEAN-level titles at the same event: Top High-Quality General Hospital System and Top High-Tech Medical Ecosystem. These awards underscore a comprehensive commitment to excellence across multiple medical disciplines, moving beyond specialized care to encompass a holistic, technology-driven approach to patient health.

A Rigorous Selection Process Based on Global Standards

The recognition bestowed upon Tam Anh General Hospital was not a mere formality but the result of a stringent five-month evaluation process. According to Master Trần Văn Doanh, Director of the Asia Business Development Research Center and a representative of the forum’s organizing committee, the selection process involved a deep dive into the operational and clinical records of dozens of organizations.

This year’s forum distributed 60 awards to more than 35 entities spanning various sectors, including healthcare, pharmaceuticals, education, banking, finance, and information technology. To qualify for the top honors, participating enterprises were required to submit comprehensive dossiers that were audited against a set of international criteria. These criteria included brand reputation within the ASEAN region, product and service quality, sustainable development strategies, regional economic contributions, social responsibility, and strict compliance with environmental, tax, and customs regulations.

For the specific title of "Southeast Asia’s Leading Reproductive Support Provider," the IVF Tam Anh Research and Treatment Center was evaluated by a council of experts on several critical pillars: clinical success rates, technological innovation, patient experience, operational management, and the ability to handle complex pathological cases. The council also looked at the hospital’s efforts in "individualized treatment," a methodology that tailors medical protocols to the unique biological and genetic profiles of each patient, rather than applying a one-size-fits-all approach.

The Technological Infrastructure of IVF Tam Anh

The success of IVF Tam Anh is rooted in its "three-legged stool" organizational model, which integrates male infertility treatment, female infertility treatment, and a state-of-the-art embryology laboratory. This internal synergy allows for seamless transitions between diagnosis and treatment, significantly reducing the time and emotional burden on patients.

A cornerstone of the facility’s regional dominance is its ISO 5 standard laboratory system. IVF Tam Anh made headlines across Asia by becoming the first unit in the region to develop a "lab-in-a-lab" model. This design involves ultra-clean micro-environments that minimize external interference during the delicate processes of gamete manipulation and embryo culture. By maintaining air quality and environmental stability at an ISO 5 level—the highest standard for such facilities—the hospital ensures that embryos have the optimal conditions for growth, which directly translates to higher implantation and pregnancy rates.

The hospital has also been a pioneer in adopting advanced reproductive technologies. These include:

• PIEZO ICSI: A specialized technique for intracytoplasmic sperm injection that uses ultrasonic vibrations to penetrate the egg membrane more gently than traditional methods, reducing potential damage to the oocyte.
• Micro-TESE (Microscopic Testicular Sperm Extraction): A micro-surgical procedure that allows doctors to find sperm in men who were previously considered sterile due to non-obstructive azoospermia.
• AI-Integrated Time-Lapse Incubators: The use of artificial intelligence and continuous camera monitoring to observe embryo development without removing them from the controlled environment of the incubator. This allows embryologists to select the most viable embryos with unprecedented precision.
• Preimplantation Genetic Testing (PGT): On-site genetic screening that helps prevent the transmission of hereditary diseases and identifies chromosomal abnormalities before an embryo is transferred.

Master Giang Huỳnh Như, Director of IVF Tam Anh in Ho Chi Minh City, noted that this technological edge is what allows the center to maintain its position at the forefront of the ASEAN medical community. "The integration of high-end technology with a comprehensive clinical approach is the advantage that has propelled IVF Tam Anh to the top spot in Southeast Asia," she stated.

Statistical Success and Global Reach

The data supporting Tam Anh’s new title is compelling. Statistical records from the hospital for the period of 2021-2025 reveal a cumulative pregnancy rate averaging 82.8%. In specific demographics, such as women under the age of 28, the success rate reaches a remarkable 90.3%. Even in highly complex cases involving patients who have failed multiple previous IVF cycles elsewhere, the cumulative pregnancy rate remains high at 72.3%.

These figures have made Tam Anh a destination for "medical tourism." Each year, the hospital system handles over 100,000 patient visits. A growing portion of this clientele consists of overseas Vietnamese and international patients traveling from the United States, France, Russia, the United Kingdom, Canada, Japan, Australia, Singapore, the Philippines, and Laos. Many of these international patients seek out Tam Anh after unsuccessful treatments in their home countries, drawn by the combination of high success rates and advanced handling of "difficult cases" such as late-age pregnancy, unexplained infertility, and co-morbidities.

Economic Competitiveness and Regional Impact

One of the most significant factors contributing to Tam Anh’s regional success is the balance between clinical efficacy and cost-effectiveness. Associate Professor Trần Quang Bình, Medical Director of Tam Anh General Hospital in Ho Chi Minh City, pointed out that Vietnam has a distinct competitive advantage in the reproductive support sector.

According to data cited from Forbes and regional market analyses, the cost of a single IVF cycle in Vietnam typically ranges between $4,000 and $5,000. This is approximately one-third of the cost in other ASEAN nations such as Thailand or Singapore, and a fraction of the cost in the United States, where a single cycle can exceed $30,000 (over 700 million VND).

"Having a domestic medical system that leads the region in reproductive support demonstrates our ability to master highly specialized techniques," Associate Professor Bình explained. "This not only reduces the need for Vietnamese citizens to seek expensive treatment abroad but also attracts international patients to Vietnam. This influx generates service revenue and creates a spillover effect for related industries such as hospitality, transportation, and tourism."

The "high-tech medical ecosystem" recognized at the forum refers to this broader impact. By creating a self-sustaining environment where research, technology, and clinical practice meet, Tam Anh is helping to build a regional "medical brand" for ASEAN, positioning the bloc as a viable alternative to traditional medical hubs in Europe or North America.

A Legacy of Excellence and Future Outlook

The awards received in Singapore are a continuation of a long-standing trend of excellence for the hospital. For five consecutive years, the IVF Tam Anh Reproductive Support Center has maintained certification from the Reproductive Technology Accreditation Committee (RTAC), the international arm of the Fertility Society of Australia (FSA). RTAC accreditation is considered the gold standard in the Asia-Pacific region for the quality and safety of assisted reproductive technology (ART) units.

The recognition at the Vietnam-ASEAN Economic Cooperation Forum 2026 serves as a powerful validation of the hospital’s strategic direction. According to the hospital leadership, these titles will further elevate the status of Vietnamese medicine on the global stage, fostering increased international cooperation and research opportunities.

The forum itself, organized annually by the Asia Business Development Research Center in collaboration with various international organizations, serves as a vital platform for investment connection and economic exchange within the ASEAN bloc. By honoring "strong brands" within the community, the forum aims to create a momentum that encourages regional enterprises to continue innovating and expanding their reach.

As Vietnam continues to integrate more deeply into the ASEAN economy, the success of institutions like Tam Anh General Hospital provides a blueprint for how service-based industries can achieve regional leadership. The combination of elite human resources, cutting-edge infrastructure, and a focus on specialized, high-demand medical services like IVF has proven to be a winning formula, not just for the hospital, but for the reputation of the nation’s healthcare system as a whole.